Posts tagged “UNC-CH”
Leslie Boney III, vice president of international, community and economic engagement for the University of North Carolina system, has been named director of the Institute for Emerging Issues.
The North Carolina Biotechnology Center awarded 17 grants and loans totaling $1,060,352 to companies, universities and nonprofit organizations across the state during the first quarter of its 2016-2017 fiscal year ending September 30.
WTW readers have no doubt noticed in the past few weeks a growing number of good stories from the North Carolina Business News Wire staff. And what better weekend to say "thank you" on behalf of WRAL TechWire while also introducing readers to a fine team of promising journalists at UNC-Chapel Hill.
What a year 2016 has turned out to be for Chapel Hill life science startup Bamboo Therapeutics. From a Papal blessing in January to a $50 million capital fund raise in February to the $150 million acquisition announced Monday (and up to $495 million more to come). NC Biotech Writer Barry Teater writes about the deal and provides the backstory on Bamboo's history.
MCNC, the non-profit operator of the North Carolina Research and Education Network (NCREN), says that as it starts a new fiscal year with growing revenue and employee base it is ready to bring broadband connectivity levels in the state to all-time highs.
The North Carolina Biotechnology Center awarded 36 loans and grants totaling nearly $2.5 million to universities and bioscience companies during the fourth quarter of its 2015-2016 fiscal year ending June 30.
What is the next step in virtual reality technology? It's "mixed reality," the merger of virtual reality with the real world, according to R. Benjamin Knapp, PhD, director of the Institute for Creativity, Arts, and Technology (ICAT) at Virginia Tech during the "How Close Can We Get to a Holodeck event at Moog fest Friday morning.
The medal has been delivered - Dr. Joseph DeSimone is one happy man. The inventor, professor, entrepreneur received the National Medal of Technology and Innovation from President Obama on Thursday in a White House ceremony, and his response when asked beforehand if he was excited he replied: "Are you kidding me? THRILLED!" By the way, he also had some ideas on innovation to share with the President. Later, he tweets: "Wow. Humbling."
In a wrapup of technology and life science news being reported by Triangle media outlets: TransEnterix cuts jobs after FDA rejects robot; G1 Therapeutics adds to a big fundraiser; and a look at the joint UNC-NCSU biomedical engineering effort.
A team of UNC seniors wins the annual startup pitch competition at UNC-Chapel Hill and $10,000 with their Unisource app. ExitEvent's Edgar Walker reports.
Hatteras Ventures, a $350 million venture capital firm in Durham, says it will invest up to $10 million in startups linked to UNC-Chapel Hill. As part of the agreement, Hatteras will manage UNC's Carolina Research Ventures investment fund.
Boosted by a $250,000 federal grant, four Triangle Universities are forming the Triangle Venture Alliance which plans to work with alumni in funding startups. The alliance is the second major boost to emerging ventures in the Triangle in two days, NCSU having announced a new $1M fund and accelerator as well on Tuesday.
Dr. Terry Magnuson, a professor and geneticist researcher, will become the new vice chancellor for research at UNC-Chapel Hill on July 1. He will replace Dr. Barbara Entwisle.
GlaxoSmithKline is boosting its own efforts to fight AIDS by closing on a deal to buy the HIV drug pipeline of Bristol-Myers Squibb . The transaction is worth as much as $1.46 billion. In May, GSK said it would invest $20 million in a deal with UNC-Chapel Hill to develop an AIDS cure.
Answered prayers? Recently blessed for its work by the Pope, Bamboo Therapeutics, a recently launched life sciences venture focusing on gene therapy to treat deadly childhood neurological disorders, has raised nearly $50 million from investors. CureDuchenne Ventures LLC, a venture philanthropy organization, is among the backers.